Novartis (India)

775 papers and 11.0k indexed citations i.

About

In recent decades, authors affiliated with Novartis (India) have published 775 papers, which have received a total of 11.0k indexed citations. Scholars at this organization have produced 135 papers in Hematology, 129 papers in Pulmonary and Respiratory Medicine and 109 papers in Oncology on the topics of Chronic Myeloid Leukemia Treatments (57 papers), Spondyloarthritis Studies and Treatments (49 papers) and Health Systems, Economic Evaluations, Quality of Life (47 papers). Their work is cited by papers focused on Immunology (2.3k citations), Molecular Biology (2.0k citations) and Oncology (1.6k citations). Authors at Novartis (India) collaborate with scholars in India, Switzerland and United States and have published in prestigious journals including New England Journal of Medicine, The Lancet and Circulation. Some of Novartis (India)'s most productive authors include Gangadhar Sunkara, Thomas Langenickel, Kamal Hamed, Parasar Pal and Ludwig Kappos.

In The Last Decade

Fields of papers published by authors at Novartis (India)

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers affiliated with Novartis (India) at the time of their publication. Nodes represent fields, and links connect fields that are likely to share authors.

Countries citing scholars working at Novartis (India)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Novartis (India). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Novartis (India) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Novartis (India) more than expected).

Rankless by CCL
2025